Job Details
We want you to feel inspired every day. We’re future-focused and our business is growing. We succeed together through passion, commitment, and teamwork, and so can you.
We are currently recruiting for an IT Support Administrator to join the Information Technology (IT) team to cover a maternity period of up to 12 Months
The purpose of this role is to perform IT Administrative and technical tasks for the team inclusive of IT purchasing, invoicing, and desktop setup for end-users. The role also co-ordinates IT services for telephony, IT hardware, external contractors, and departmental moves.
Your responsibilities in this role would be:
Lifetime user management:
Responsible for tracking Validated User Access forms across the business.
Ensuring the starters, movers & leavers process is controlled and managed.
IT Administration:
Administer IT purchasing and receipting of hardware, software, consumables & licensing and ensure fixed assets are recorded.
Ensuring all telephony accounts are controlled and administration requests are carried out with network service provider.
Technical support:
Responsible for installing and upgrading Windows 10/11 laptops and PCs.
1st line Helpdesk support to the business to include laptop builds for new and repurposed equipment, password resetting and account unlocking.
Liaising with third-party contractors for equipment repairs, scheduled services and equipment moves.
Profile description:
We are looking for:
Good standard of secondary education (GCSE) in English, Maths and Science.
Experience of working in an IT and/or administrative support role
Good administrative skills with the ability to prioritise tasks
Proficient in the use of MS Excel and other MS Office Applications
Some technical working knowledge of MS Windows versions 10&11
Knowledge of Active Directory and Account Access Control requirements would be beneficial
A good understanding of Enterprise Resource Management Systems or IT Helpdesk case management systems will be useful.
A confident communicator who can understand basic technical IT hardware and software problems.
About Us:
Oxford Biomedica is a quality and innovation-led viral vector CDMO (Contract Development and Manufacturing Organization) with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus, and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.
What’s in it for you:
Highly competitive total reward packages
Wellbeing programmes
Development opportunities
Welcoming, friendly, supportive colleagues
A diverse and inclusive working environment
Our values are: Deliver Innovation, Be Inspiring and Have Integrity
State of the art laboratory and manufacturing facilities
Collaborate. Contribute. Change lives.
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.